The role of hormones in renal disease and ischemia-reperfusion injury

The patients with renal diseases, especially end-stage renal disease (ESRD), are at high risk of developing cardiovascular disturbances. Some hormones such as brain natriuretic peptide appear to be important serum biomarkers in predicting cardiac death in ESRD patients. Renal diseases cause inflamma...

Full description

Bibliographic Details
Main Authors: Shokofeh Banaei, Lotfollah Rezagholizadeh
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2019-05-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:http://ijbms.mums.ac.ir/article_12448_aa0d7fad5b22dc3f4b91e296f23bc42e.pdf
_version_ 1818068522372169728
author Shokofeh Banaei
Lotfollah Rezagholizadeh
author_facet Shokofeh Banaei
Lotfollah Rezagholizadeh
author_sort Shokofeh Banaei
collection DOAJ
description The patients with renal diseases, especially end-stage renal disease (ESRD), are at high risk of developing cardiovascular disturbances. Some hormones such as brain natriuretic peptide appear to be important serum biomarkers in predicting cardiac death in ESRD patients. Renal diseases cause inflammation, anemia, uremic toxins, fluid overload, and electrolyte disturbance. Kidney transplantation is considered the choice treatment for patients with ESRD. Ischemia-reperfusion (IR), which occurs during renal transplantation is one of the factors that affect the outcome of renal transplantation. Renal graft rejection is the result of IR injury and there is no effective treatment to prevent IR injury. Reperfusion after ischemia may cause injury through generation of reactive oxygen and nitrogen species, inflammatory responses by increased levels of tumor necrosis factor-α (TNF-α) and interleukins (IL), and apoptotic processes, and leads to acute kidney injury (AKI). Thus, antioxidant, anti-apoptotic and anti-inflammatory hormones, which inhibit these pathways, can protect against IR injury and improve transplanted renal function in patients with ESRD.
first_indexed 2024-12-10T15:40:55Z
format Article
id doaj.art-4d45ee75111c4889815516d4c6f474e7
institution Directory Open Access Journal
issn 2008-3866
2008-3874
language English
last_indexed 2024-12-10T15:40:55Z
publishDate 2019-05-01
publisher Mashhad University of Medical Sciences
record_format Article
series Iranian Journal of Basic Medical Sciences
spelling doaj.art-4d45ee75111c4889815516d4c6f474e72022-12-22T01:43:06ZengMashhad University of Medical SciencesIranian Journal of Basic Medical Sciences2008-38662008-38742019-05-0122546947610.22038/ijbms.2019.34037.809512448The role of hormones in renal disease and ischemia-reperfusion injuryShokofeh Banaei0Lotfollah Rezagholizadeh1Social Determinants of Health (SDH) Research Center, Ardabil University of Medical Sciences, Ardabil, Iran|Department of Physiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, IranDepartment of Biochemistry, School of Medicine, Ardabil University of Medical Sciences, Ardabil, IranThe patients with renal diseases, especially end-stage renal disease (ESRD), are at high risk of developing cardiovascular disturbances. Some hormones such as brain natriuretic peptide appear to be important serum biomarkers in predicting cardiac death in ESRD patients. Renal diseases cause inflammation, anemia, uremic toxins, fluid overload, and electrolyte disturbance. Kidney transplantation is considered the choice treatment for patients with ESRD. Ischemia-reperfusion (IR), which occurs during renal transplantation is one of the factors that affect the outcome of renal transplantation. Renal graft rejection is the result of IR injury and there is no effective treatment to prevent IR injury. Reperfusion after ischemia may cause injury through generation of reactive oxygen and nitrogen species, inflammatory responses by increased levels of tumor necrosis factor-α (TNF-α) and interleukins (IL), and apoptotic processes, and leads to acute kidney injury (AKI). Thus, antioxidant, anti-apoptotic and anti-inflammatory hormones, which inhibit these pathways, can protect against IR injury and improve transplanted renal function in patients with ESRD.http://ijbms.mums.ac.ir/article_12448_aa0d7fad5b22dc3f4b91e296f23bc42e.pdfAcute kidney injury AntioxidantHormonesIschemia-reperfusion injuryRenal disease
spellingShingle Shokofeh Banaei
Lotfollah Rezagholizadeh
The role of hormones in renal disease and ischemia-reperfusion injury
Iranian Journal of Basic Medical Sciences
Acute kidney injury Antioxidant
Hormones
Ischemia-reperfusion injury
Renal disease
title The role of hormones in renal disease and ischemia-reperfusion injury
title_full The role of hormones in renal disease and ischemia-reperfusion injury
title_fullStr The role of hormones in renal disease and ischemia-reperfusion injury
title_full_unstemmed The role of hormones in renal disease and ischemia-reperfusion injury
title_short The role of hormones in renal disease and ischemia-reperfusion injury
title_sort role of hormones in renal disease and ischemia reperfusion injury
topic Acute kidney injury Antioxidant
Hormones
Ischemia-reperfusion injury
Renal disease
url http://ijbms.mums.ac.ir/article_12448_aa0d7fad5b22dc3f4b91e296f23bc42e.pdf
work_keys_str_mv AT shokofehbanaei theroleofhormonesinrenaldiseaseandischemiareperfusioninjury
AT lotfollahrezagholizadeh theroleofhormonesinrenaldiseaseandischemiareperfusioninjury
AT shokofehbanaei roleofhormonesinrenaldiseaseandischemiareperfusioninjury
AT lotfollahrezagholizadeh roleofhormonesinrenaldiseaseandischemiareperfusioninjury